George W. Lloyd - Net Worth and Insider Trading

George W. Lloyd Net Worth

The estimated net worth of George W. Lloyd is at least $26 Million dollars as of 2024-04-27. George W. Lloyd is the EVP, Investments & CLO of Royalty Pharma PLC and owns about 926,831 shares of Royalty Pharma PLC (RPRX) stock worth over $26 Million. Details can be seen in George W. Lloyd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that George W. Lloyd has not made any transactions after 2023-06-06 and currently still holds the listed stock(s).

Transaction Summary of George W. Lloyd

To

George W. Lloyd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, George W. Lloyd owns 1 companies in total, including Royalty Pharma PLC (RPRX) .

Click here to see the complete history of George W. Lloyd’s form 4 insider trades.

Insider Ownership Summary of George W. Lloyd

Ticker Comapny Transaction Date Type of Owner
RPRX Royalty Pharma PLC 2023-06-06 EVP & Investments & GC

George W. Lloyd Latest Holdings Summary

George W. Lloyd currently owns a total of 1 stock. George W. Lloyd owns 926,831 shares of Royalty Pharma PLC (RPRX) as of June 6, 2023, with a value of $26 Million.

Latest Holdings of George W. Lloyd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RPRX Royalty Pharma PLC 2023-06-06 926,831 28.00 25,951,268

Holding Weightings of George W. Lloyd


George W. Lloyd Form 4 Trading Tracker

According to the SEC Form 4 filings, George W. Lloyd has made a total of 20 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Royalty Pharma PLC is the sale of 192,221 shares on June 6, 2023, which brought George W. Lloyd around $6 Million.

Insider Trading History of George W. Lloyd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

George W. Lloyd Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

George W. Lloyd Ownership Network

Ownership Network List of George W. Lloyd

No Data

Ownership Network Relation of George W. Lloyd


George W. Lloyd Owned Company Details

What does Royalty Pharma PLC do?

Who are the key executives at Royalty Pharma PLC?

George W. Lloyd is the EVP & Investments & GC of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .

Royalty Pharma PLC (RPRX) Insider Trades Summary

Over the past 18 months, George W. Lloyd made 5 insider transaction in Royalty Pharma PLC (RPRX) with a net sale of 420,000. Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net sale of 2,479,950 shares made by Rory B Riggs , a net purchase of 600,000 shares made by Pablo G. Legorreta , and a net sale of 180,000 shares made by Terrance P. Coyne .

In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,484,548 shares of Royalty Pharma PLC (RPRX) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 3,884,548 shares.

Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Royalty Pharma PLC Insider Transactions

No Available Data

George W. Lloyd Mailing Address

Above is the net worth, insider trading, and ownership report for George W. Lloyd. You might contact George W. Lloyd via mailing address: C/o Royalty Pharma Plc, 110 East 59th Street, New York Ny 10022.

Discussions on George W. Lloyd

No discussions yet.